NCT04421196

Opioid-free Total Hip Arthroplasty

Opioid-free Total Hip Arthroplasty: A Randomized Controlled Trial

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Johns Hopkins University · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The primary objective of investigators' proposed study is to demonstrate that the following two cohorts undergoing total hip arthroplasty will have equivalent visual analog scale (VAS) scores up to 3 months post-operatively: one that is administered a modified multimodal analgesic pathway without opioids and the other administered the current standard multimodal analgesic pathway used at Johns Hopkins Bayview Hospital (which includes opioids). The secondary objective is to demonstrate that these cohorts will also have equivalent functional outcomes as determined by both objective measures (such as hip range of motion) and patient-reported outcome measures, such as the Hip Disability and Osteoarthritis Outcome Score (HOOS) and the University of California at Los Angeles (UCLA) activity score.

Conditions

• Hip Osteoarthritis

Interventions

Type	Name	Description
OTHER	Exclusion of opioid analgesics	The intervention involves removing the option of patients having an opioid analgesic at any time point during the perioperative period.

Timeline

• Start date: 2022-09-15
• Primary completion: 2023-09-01
• Completion: 2023-12-01
• First posted: 2020-06-09
• Last updated: 2022-09-21